myositis treatment
Intravenous Immune Globulin (IVIg) – A newly approved therapeutic option for the treatment of adult dermatomyositis
MSU Zoom Video Session Video session using ZoomLearn about Octapharma’s IVIg therapy and the results of the landmark Progress in Dermatomyositis (ProDERM) study. The successful ProDERM Study resulted in the first and only FDA-approved IVIg therapy for DM in adults. MSU and Octapharma USA are proud to co-sponsor this exciting educational program with Dr. Rohit Aggarwal.
Immune Globulin Therapy: All your questions answered
MSU Zoom Video Session Video session using ZoomJoin MSU for a webinar with CSI Pharmacy, Immune Globulin Therapy: All your questions answered. This is your opportunity to ask the experts, including patient experts, the questions you have about the therapy such as side effects, brand differences, IV vs SubQ, site of care, insurance, out-of-pocket costs, copay assistance programs and more.